Michael Schubert, PhD, is a veteran science and medicine communicator. He holds graduate degrees in biochemistry and molecular biology with a research focus on chromatin structure and function and has written on subjects from subspeciality pathology to fictional science. In addition to writing and editing, he is co-director of the Digital Communications Fellowship in Pathology and Course Trainer at the Lightyear Foundation, an initiative aimed at making science accessible to all.
Articles by Michael Schubert, PhD
|4 min read
One Health in the Lab: Healthy Planet, Healthy People
One Health expert Oladele Ogunseitan explains how human, animal, and environmental health are linked, and what clinical labs can do to drive advances in all three
Updated |5+ min read
A Timeline of Laboratory-Developed Test Regulation in the US
The century-long history of the U.S. FDA’s relationship with LDTs
|5 min read
Precarious Prescriptions: Lab Testing and Coverage for GLP-1 Drugs
Julie Schulz, MD, MPH, discusses GLP-1 receptor agonists, the lab’s role in prescribing, and the future of the GLP-1 drug industry
|5 min read
A Year of Advancement: AACR Cancer Progress Report 2024
Screening successes, emerging technologies, precision treatments, and other steps forward from the AACR Cancer Progress Report 2024
|5+ min read
FDA, CLIA, and ISO—Which Regulations Apply to Your Clinical Lab?
Experts Julie Ballard and Lindsay Strotman help you navigate the complexities of FDA, CLIA, and ISO standards for the clinical lab
|5+ min read
5 Clinical Laboratories Leading the Way in Patient Care
Trailblazing labs are among the first to adopt new tests and treatments for longstanding challenges
|4 min read
Improving Indoor Air Quality in Clinical Laboratories: Best Practices for Safety and Compliance
A guide to indoor air quality in the clinical lab—understanding the hazards, monitoring risk, and taking action to prevent issues
|2 min read
New Guidelines for Bone Cancer Biopsy
Two consortia have issued best practice recommendations for tissue sampling in osteosarcoma and Ewing sarcoma
|2 min read
Endometriosis Increases Risk of Ovarian Cancer
Some subtypes of endometriosis can raise patients’ cancer risk as much as 19-fold
Updated |2 min read
Is It Time for HER2-Low Breast Cancer?
Evaluating the evidence for, and against, distinguishing between HER2-low and HER2-zero breast cancers
|2 min read
New Biomarker Candidates for Colon Cancer
New biomarker candidates may help determine which colon cancer patients are most likely to benefit from chemotherapy
|4 min read
